Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct:143:109888.
doi: 10.1016/j.mehy.2020.109888. Epub 2020 May 27.

Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?

Irina Bobkova  1 , Elena Kamyshova  2 , Tatiana Rudenko  1 , Ekaterina Stavrovskaya  1 , Sergey Moiseev  1
Affiliations
Comment

Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?

Irina Bobkova et al. Med Hypotheses. 2020 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Comment on

References

    1. Roncati L., Gallo G., Manenti A. Renin-angiotensin system: the unexpected flaw inside the human immune system revealed by SARS-CoV-2, 2020 Mar 21. Med Hypotheses. 2020;140 doi: 10.1016/j.mehy.2020.109686. - DOI - PMC - PubMed
    1. Zhang H., Penninger J.M., Li Y. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586–590. doi: 10.1007/s00134-020-05985-9. - DOI - PMC - PubMed
    1. Gu J., Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol. 2007;170(4):1136–1147. doi: 10.2353/ajpath.2007.061088. - DOI - PMC - PubMed
    1. Speth R.C. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections. Drug Dev Res. 2020 - PMC - PubMed